Detalhe da pesquisa
1.
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
Clin Infect Dis
; 75(1): e509-e515, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971385
2.
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Breast Cancer Res Treat
; 185(1): 195-204, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918117
3.
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Ann Surg Oncol
; 27(3): 765-771, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907749
4.
Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
Am J Obstet Gynecol
; 218(4): 436.e1-436.e7, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353030
5.
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Int J Cancer
; 138(3): 612-9, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26264211
6.
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.
Gynecol Oncol
; 140(2): 259-63, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731723
7.
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Gynecol Oncol
; 136(1): 3-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25238946
8.
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.
Int J Gynecol Cancer
; 25(9): 1724-30, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397156
9.
Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data.
Int J Gynecol Cancer
; 25(6): 1000-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26098088
10.
MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
J Biol Chem
; 287(42): 34970-34978, 2012 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927443
11.
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.
Gynecol Oncol
; 130(1): 19-24, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623830
12.
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
Gynecol Oncol
; 131(1): 207-12, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23877012
13.
Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancers.
Am J Obstet Gynecol
; 208(6): 501.e1-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23507546
14.
Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.
Am J Obstet Gynecol
; 209(6): 576.e1-576.e16, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23933223
15.
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
PLoS One
; 18(12): e0294448, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039311
16.
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.
J Biol Chem
; 291(43): 22851, 2016 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825089
17.
Fascin protein is critical for transforming growth factor ß protein-induced invasion and filopodia formation in spindle-shaped tumor cells.
J Biol Chem
; 286(45): 38865-75, 2011 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914811
18.
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Gynecol Oncol
; 124(1): 119-24, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22032837
19.
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
Nature
; 439(7074): 353-7, 2006 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-16273092
20.
Preoperative enoxaparin is safe to use in major gynecologic surgery for prophylaxis of venous thromboembolism: a retrospective cohort study.
Int J Gynecol Cancer
; 22(4): 681-5, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22343972